Maywufa Company Ltd. (1731.TW)
TWD 22.75
(-0.66%)
TWD 22.75
(-0.66%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 257.91 Million TWD | 10.99% |
| 2022 | 232.37 Million TWD | -2.44% |
| 2021 | 238.18 Million TWD | 42.16% |
| 2020 | 167.54 Million TWD | -12.83% |
| 2019 | 192.2 Million TWD | -11.65% |
| 2018 | 217.54 Million TWD | -16.37% |
| 2017 | 260.11 Million TWD | -14.18% |
| 2016 | 303.1 Million TWD | 5.35% |
| 2015 | 287.7 Million TWD | 28.28% |
| 2014 | 224.28 Million TWD | -0.39% |
| 2013 | 225.15 Million TWD | 9.38% |
| 2012 | 205.85 Million TWD | 34.48% |
| 2011 | 153.07 Million TWD | -14.17% |
| 2010 | 178.35 Million TWD | -3.71% |
| 2009 | 185.23 Million TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 266.31 Million TWD | 4.9% |
| 2024 Q1 | 253.86 Million TWD | -1.57% |
| 2023 FY | 257.91 Million TWD | 10.99% |
| 2023 Q1 | 220.85 Million TWD | -4.96% |
| 2023 Q2 | 224.63 Million TWD | 1.71% |
| 2023 Q4 | 257.91 Million TWD | 1.89% |
| 2023 Q3 | 253.13 Million TWD | 12.69% |
| 2022 Q3 | 229.4 Million TWD | -4.29% |
| 2022 Q2 | 239.67 Million TWD | 3.19% |
| 2022 FY | 232.37 Million TWD | -2.44% |
| 2022 Q4 | 232.37 Million TWD | 1.3% |
| 2022 Q1 | 232.26 Million TWD | -2.49% |
| 2021 Q1 | 168.96 Million TWD | 0.85% |
| 2021 FY | 238.18 Million TWD | 42.16% |
| 2021 Q2 | 221.35 Million TWD | 31.0% |
| 2021 Q4 | 238.18 Million TWD | -0.37% |
| 2021 Q3 | 239.06 Million TWD | 8.0% |
| 2020 FY | 167.54 Million TWD | -12.83% |
| 2020 Q1 | 180.39 Million TWD | -6.14% |
| 2020 Q2 | 187.05 Million TWD | 3.69% |
| 2020 Q3 | 178.74 Million TWD | -4.44% |
| 2020 Q4 | 167.54 Million TWD | -6.27% |
| 2019 Q1 | 207.69 Million TWD | -4.53% |
| 2019 FY | 192.2 Million TWD | -11.65% |
| 2019 Q2 | 199.22 Million TWD | -4.08% |
| 2019 Q4 | 192.2 Million TWD | 1.97% |
| 2019 Q3 | 188.48 Million TWD | -5.39% |
| 2018 Q4 | 217.54 Million TWD | -8.15% |
| 2018 Q1 | 248.7 Million TWD | -4.39% |
| 2018 Q2 | 243.74 Million TWD | -1.99% |
| 2018 Q3 | 236.84 Million TWD | -2.83% |
| 2018 FY | 217.54 Million TWD | -16.37% |
| 2017 Q1 | 292.52 Million TWD | -3.49% |
| 2017 FY | 260.11 Million TWD | -14.18% |
| 2017 Q4 | 260.11 Million TWD | -10.57% |
| 2017 Q3 | 290.86 Million TWD | -2.65% |
| 2017 Q2 | 298.78 Million TWD | 2.14% |
| 2016 Q2 | 279.7 Million TWD | 0.14% |
| 2016 Q1 | 279.32 Million TWD | -2.91% |
| 2016 FY | 303.1 Million TWD | 5.35% |
| 2016 Q4 | 303.1 Million TWD | 11.39% |
| 2016 Q3 | 272.1 Million TWD | -2.72% |
| 2015 Q4 | 287.7 Million TWD | 3.66% |
| 2015 FY | 287.7 Million TWD | 28.28% |
| 2015 Q2 | 241.74 Million TWD | 0.2% |
| 2015 Q3 | 277.54 Million TWD | 14.81% |
| 2015 Q1 | 241.25 Million TWD | 7.57% |
| 2014 Q3 | 223.28 Million TWD | -2.15% |
| 2014 Q2 | 228.17 Million TWD | -2.74% |
| 2014 FY | 224.28 Million TWD | -0.39% |
| 2014 Q1 | 234.6 Million TWD | 4.2% |
| 2014 Q4 | 224.28 Million TWD | 0.45% |
| 2013 Q3 | 217.9 Million TWD | 13.53% |
| 2013 Q4 | 225.15 Million TWD | 3.33% |
| 2013 FY | 225.15 Million TWD | 9.38% |
| 2013 Q1 | 186.94 Million TWD | -9.19% |
| 2013 Q2 | 191.93 Million TWD | 2.67% |
| 2012 Q1 | 156.1 Million TWD | 1.98% |
| 2012 Q3 | 167.18 Million TWD | -1.9% |
| 2012 Q4 | 205.85 Million TWD | 23.13% |
| 2012 FY | 205.85 Million TWD | 34.48% |
| 2012 Q2 | 170.42 Million TWD | 9.18% |
| 2011 Q4 | 153.07 Million TWD | -6.59% |
| 2011 FY | 153.07 Million TWD | -14.17% |
| 2011 Q1 | 161.37 Million TWD | -9.52% |
| 2011 Q3 | 163.87 Million TWD | -1.51% |
| 2011 Q2 | 166.39 Million TWD | 3.11% |
| 2010 Q4 | 178.35 Million TWD | 0.0% |
| 2010 FY | 178.35 Million TWD | -3.71% |
| 2009 FY | 185.23 Million TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Grape King Bio Ltd | 737.18 Million TWD | 65.014% |
| Standard Chem & Pharm CO., LTD. | 1.61 Billion TWD | 84.03% |
| ScinoPharm Taiwan, Ltd. | 1.51 Billion TWD | 82.937% |
| Lotus Pharmaceutical Co., Ltd. | 3.77 Billion TWD | 93.169% |
| LIWANLI Innovation Co., Ltd. | 60.81 Million TWD | -324.063% |
| YungShin Global Holding Corporation | 2.77 Billion TWD | 90.699% |
| PhytoHealth Corporation | 163.09 Million TWD | -58.14% |
| SCI Pharmtech, Inc. | 529.53 Million TWD | 51.295% |
| Formosa Laboratories, Inc. | 1.59 Billion TWD | 83.855% |
| PharmaEssentia Corporation | 1.45 Billion TWD | 82.318% |
| Bora Pharmaceuticals Co., LTD. | 2.15 Billion TWD | 88.038% |